Table 2.
RT potential in the presence of RT-stimulating compounds; the influence of the STOP codon identity and of the +4 nucleotide context
| STOP CODON |
||||||
|---|---|---|---|---|---|---|
| UGA | > | UAG | > | UAA | RT-STIMULATING DRUG | REFERENCE |
| C>U>A>G | C>U∼G∼C | C>U>G∼A | G418 | Howard et al.32 | ||
| C>U>A∼G | C>U∼G∼C | C ∼U∼G∼C | Gentamicin | |||
| C>U∼A>G | C ∼U∼G∼C | C ∼U∼G∼C | Paromomycin | |||
| C>A∼G>U | U>C∼G>A | C>U>G>A | G418 | Manuvakhova et al.33 | ||
| C>A=G >U | U>C=G >A | C>G>A=U | Gentamicin | |||
| C>A≥G>U | C>A=G =U | G=U >A=C | Paromomycin | |||
| C>A=G =U | G>C=U >A | U>C>A=G | Neomycin | |||
| C>A>G>U | U>C>A=G | U>A=C =G | Sisomycin | |||
| C>U>A=G | G>C>A>U | A>U>C>G | Lividomycin | |||
| C>A∼G∼U | C>A∼G∼U | C>A∼G∼U | Gentamicin | Floquet et al.31 | ||